Oxalic Acid

Oxalic Acid

SCHEMBL7966080

O=C(O)C(=O)O.OC1(c2cncc3ccccc23)CCN(CCCOc2ccccc2)CC1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.54
ALDH1A1 P00352 7/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
LMNA P02545 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
GCGR P47871 1/20 0.44
HRH3 Q9Y5N1 4/20 0.43
KCNH2 Q12809 2/20 0.43
HRH4 Q9H3N8 2/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HRH1 P35367 1/20 0.43
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
NPY1R P25929 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966082 0.86 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
Oxalic Acid SCHEMBL7966526 0.78 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7962445 0.77 HTR1A (0.42) KMT2AMEN1HRH3
SCHEMBL7965454 0.74 OPRL1 (0.36) KDM4EKMT2AMEN1HRH3HRH1
SCHEMBL11717047 0.73 ALDH1A1 (0.74) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
SCHEMBL7962754 0.72 ALDH1A1 (0.56) KDM4EALDH1A1SMN1; SMN2LMNAKMT2A
Acrylic Acid SCHEMBL7963757 0.72 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2LMNAKMT2AMEN1
SCHEMBL7964475 0.72 CYP11B2 (0.41) ALDH1A1KMT2AMEN1
Oxalic Acid SCHEMBL5856230 0.72 KDM4E (1.00) KDM4EALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL28396299 0.71 CYP11B2 (0.43) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6242450-B1 SUBSTITUTED PIPERIDINES ELI LILLY AND COMPANY 2001-06-05 US disclosed
WO-2000006166-A1 5-HT1F ANTAGONISTS ELI LILLY AND COMPANY (US) 2000-02-10 WO disclosed
EP-0976746-A1 5-HT1F antagonists ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed